Betty Malanowski, BS, ODS, IMG 10/1/26 Betty Malanowski, BS, ODS, IMG 10/1/26

QC Corner Coding Tip: Uterine corpus/Endometrial carcinoma and Carcinosarcoma

For Uterine corpus /Endometrial carcinoma and Carcinosarcoma if it is FIGO 2 or FIGO 3 code to Seer Summary Stage 2 REGIONAL by direct extension.

Barbara DeArmon-Neyland, BS, ODS 10/1/26 Barbara DeArmon-Neyland, BS, ODS 10/1/26

CNS Part 1 Highlights

Quick Coding Reminders for Brain and CNS Tumor Reporting

Mahima Jain, MBA 10/1/26 Mahima Jain, MBA 10/1/26

The Case Doesn’t End With Submission: What Happens After an Abstract Reaches FCDS?

Follow the journey of a cancer case from submission to quality assurance and cancer surveillance.

Florida Cancer Data System 10/1/26 Florida Cancer Data System 10/1/26

The Fall 2026 FCDS Memo Crossword

United in Awareness

Take a few minutes to unwind with this quarter's FCDS Memo crossword. United in Awareness celebrates Sarcoma and Bone Cancer Awareness Month, World Cancer Awareness Month, and Childhood Cancer Awareness Month through a fun and engaging challenge.

Florida Cancer Data System 10/1/26 Florida Cancer Data System 10/1/26

The Summer 2026 FCDS Memo Crossword - Answer Page

Florida Cancer Data System 6/29/26 Florida Cancer Data System 6/29/26

The Spring 2026 FCDS Memo Crossword - Answer Page

Mahima Jain, MBA 6/29/26 Mahima Jain, MBA 6/29/26

Stronger Together: Leveraging Technology to Empower the Oncology Data Specialist Workforce

AI-powered technology enhances efficiency in cancer registries, but it is the expertise of Oncology Data Specialists that ensures accurate, high-quality data and meaningful impact on patient care.

Betty Malanowski, BS, ODS, IMG 3/19/26 Betty Malanowski, BS, ODS, IMG 3/19/26

Coding Grade

Important Grade codes for Uterus, Peritoneum, Ovary, Fallopian Tubes and GI NETs

Barbara DeArmon-Neyland, BS, ODS-C, Rhonda Buchenhain BS, RHIA 12/22/25 Barbara DeArmon-Neyland, BS, ODS-C, Rhonda Buchenhain BS, RHIA 12/22/25

Do not use the Solid Tumor Rules (STRs) for Tumors Described as Metastases.

This post is a reminder to abstractors that the solid tumor rules should not be applied to tumors described as metastases when determining multiple primaries.

Betty Malanowski, BS, ODS, IMG 12/22/25 Betty Malanowski, BS, ODS, IMG 12/22/25

Neuroendocrine System Overview

Classification of Neuroendocrine Neoplasms

Barbara DeArmon-Neyland, BS, ODS 12/22/25 Barbara DeArmon-Neyland, BS, ODS 12/22/25

Biochemical Recurrence in Prostate Cancer: Is it Reportable

This post provides information on understanding the reportability of biochemical references in prostate cancer.

Mahima Jain, MBA 9/23/25 Mahima Jain, MBA 9/23/25

Understanding Testicular Cancer Coding: A Guide for Cancer Registrars

This article aims to clarify the use of site codes for testicular cancer, with a focus on the overused site code C629 (Testis, NOS)

Livia Harding, BS 9/23/25 Livia Harding, BS 9/23/25

Doing Your Part: The Importance of Reporting

The Importance of Cancer Reporting to Central Cancer Registries

Barbara Neyland, BS, ODS-C, Mahima Jain, MBA 9/23/25 Barbara Neyland, BS, ODS-C, Mahima Jain, MBA 9/23/25

STRs when to apply histology codes 8085 and 8086

This article aims to clarify the use of site codes for testicular cancer, with a focus on the overused site code C629 (Testis, NOS)

Barbara Neyland, BS, ODS-C, Sasha Raju MPH, ODS-C 9/23/25 Barbara Neyland, BS, ODS-C, Sasha Raju MPH, ODS-C 9/23/25

Refining Histology Coding for GYN Malignancies: Focus on Serous Carcinoma

This article provides guidelines for assigning the correct histology code for GYN malignancies with a diagnosis of serous carcinoma.

Betty Malanowski, BS, ODS, IMG 9/23/25 Betty Malanowski, BS, ODS, IMG 9/23/25

Coding Fine Needle Aspiration

Calcitonin as a cancer marker and Fine Needle Aspiration (FNA)

Can’t find what you’re looking for?

Type in a few key words and we’ll see if we can locate it for you:

Can’t find what you’re looking for?

The FCDS Memo